Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thrombotic Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01999179
What this trial is testing

Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis

Who this might be right for
Venous ThrombosisNeoplasms
Medical College of Wisconsin 27
Testing effectiveness (Phase 2)Study completedNCT00632242
What this trial is testing

ARC1779 Injection in Patients With Von Willebrand Factor-Related Platelet Function Disorders

Who this might be right for
Purpura, Thrombotic ThrombocytopenicVon Willebrand Disease Type-2b
Archemix Corp. 28
Large-scale testing (Phase 3)Looking for participantsNCT05338190
What this trial is testing

Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Assistance Publique - Hôpitaux de Paris 132
Testing effectiveness (Phase 2)Looking for participantsNCT07175493
What this trial is testing

CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia

Who this might be right for
Autoimmune CytopeniaImmune Thrombocytopenia (ITP)Autoimmune Hemolytic Anemia+1 more
Keymed Biosciences Co.Ltd 158
Large-scale testing (Phase 3)Not Yet RecruitingNCT07455006
What this trial is testing

Safety and Efficacy Study of QL0911 to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients

Who this might be right for
Thrombocytopenia, Immune
Qilu Pharmaceutical Co., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT00625443
What this trial is testing

Phase 2, Parallel Group, Rollover Study of AKR-501 in Patients With ChronicITP Who Completed 28 Days of Study Treatment in Protocol 501-CL-003

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Eisai Inc. 53
Large-scale testing (Phase 3)Study completedNCT02279173
What this trial is testing

Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Amgen 203
Early research (Phase 1)Study completedNCT03275454
What this trial is testing

Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple- Dose BIVV009 in Participants With Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
Bioverativ, a Sanofi company 12
Post-approval studies (Phase 4)Ended earlyNCT05066789
What this trial is testing

CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 4

Who this might be right for
Coronary Artery Disease
Samsung Medical Center 100
Early research (Phase 1)UnknownNCT02403440
What this trial is testing

Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
Jiangsu HengRui Medicine Co., Ltd. 24
Large-scale testing (Phase 3)Study completedNCT01444417
What this trial is testing

Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients

Who this might be right for
Idiopathic Thrombocytopenic PurpuraThrombocytopeniaThrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)+3 more
Amgen 62
Large-scale testing (Phase 3)WithdrawnNCT02649504
What this trial is testing

Rituximab and Dexamethasone Followed by Mycophenolate Mofetil or Placebo in Patients With Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Weill Medical College of Cornell University
Not applicableStudy completedNCT01549184
What this trial is testing

Retrospective Analysis of the Safety and Efficacy of Hydroxychloroquine in Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaSystemic Lupus Erythematosus
Henri Mondor University Hospital 40
Not applicableLooking for participantsNCT07059026
What this trial is testing

Thrombotic Microangiopathy (TMA) Associated With Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Adult Patients

Who this might be right for
Thrombotic Microangiopathy
ITAC (Instituto de Trasplantes y Alta Complejidad) 200
Post-approval studies (Phase 4)Study completedNCT01390649
What this trial is testing

A Safety Study of Intravenous Immunoglobulin in Patients With Chronic Immune Thrombocytopenic Purpura (ITP)

Who this might be right for
Immune Thrombocytopenic Purpura
CSL Behring 57
Large-scale testing (Phase 3)Study completedNCT05185804
What this trial is testing

Clinical Trial of Dimolegin (DD217) in Prevention of Thrombotic Complications in Patients With COVID-19

Who this might be right for
COVID-19Venous Thromboembolism
PharmaDiall Ltd. 399
Not applicableEnded earlyNCT04904276
What this trial is testing

Observational Study of Fostamatinib as Second Line Therapy in Adult Patients With Immune Thrombocytopenia (ITP) and Insufficient Response to a Prior Therapy

Who this might be right for
ITPImmune Thrombocytopenia
Rigel Pharmaceuticals 16
Not applicableUnknownNCT06046807
What this trial is testing

Long-Term Post Thrombotic Syndrome Assessment (CELEST Long Term).

Who this might be right for
Post Thrombotic Syndrome
Laboratoires Innothera 288
Not applicableUnknownNCT03377439
What this trial is testing

The Association Between Platelet Reactivity and Bleeding Risk in Adult ITP

Who this might be right for
Immune Thrombocytopenia
Shandong University 400
Testing effectiveness (Phase 2)Looking for participantsNCT07297563
What this trial is testing

Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 160
Next Page